An Open Label, Multi Centre, Phase II Study to Evaluate the Safety and Efficacy of Coramsine Injection in Patients with Renal Cell Carcinoma.

Trial Profile

An Open Label, Multi Centre, Phase II Study to Evaluate the Safety and Efficacy of Coramsine Injection in Patients with Renal Cell Carcinoma.

Suspended
Phase of Trial: Phase II

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs SBP 002 (Primary)
  • Indications Renal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 30 Aug 2011 Actual initiation date (30 Jun 2006) added and official Title amended as reported by Australian New Zealand Clinical Trials Registry.
    • 30 Aug 2011 New source identified and integrated (Australian New Zealand Clinical Trials Registry; ACTRN12606000099527).
    • 16 Nov 2006 Status change
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top